Stock listing

TWSE:4155 OK Biotech Co., Ltd. (訊映) 股價

Follow OK Biotech Co., Ltd. into a list and get an email when it puts out news.

Share price · TWSE:4155

$15.50 TWD -2.45 (-13.6%)

Close on Nov 20, 2026

Past year -7.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$15.20 – $16.00 TWDNov 20, 2026
Volume
1.60M sharesNov 20, 2026
Market cap
$1.82B TWDAt the close on Nov 20, 2026 · price × 117.2M shares outstanding
52-week range
$14.34 – $19.30 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$11.85M TWDMedian day 248,123 shares · 4 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
OK Biotech Co., Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TWSE:4155 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$15.50-2.45-13.6%$15.50$16.00$15.201,601,324
$17.95-0.60-3.2%$18.55$18.55$17.102,172,125
$18.55+1.00+5.7%$17.55$19.30$16.903,648,122
$17.55+0.20+1.2%$18.25$18.85$17.551,822,369
$17.35+0.65+3.9%$16.90$18.30$16.901,435,210
$16.70-0.20-1.2%$17.10$17.40$16.60586,411
$16.90-0.60-3.4%$17.25$17.95$16.501,188,733
$17.50-1.00-5.4%$17.80$18.65$17.251,508,723
$18.50+0.60+3.4%$18.50$18.85$17.652,752,445
$17.90+1.55+9.5%$15.65$17.90$15.251,473,452
$16.35-0.45-2.7%$16.80$17.05$16.30764,230
$16.80+0.15+0.9%$16.80$16.85$16.35335,249
$16.65-0.65-3.8%$17.25$17.30$16.30752,115
$17.30+0.50+3.0%$16.15$17.45$16.15868,222
$16.80-0.25-1.5%$17.05$17.40$16.75615,921
$17.05+0.65+4.0%$16.40$17.45$16.251,089,328
$16.40-0.10-0.6%$16.50$16.75$16.30453,005
$16.50-0.30-1.8%$16.60$17.05$16.20840,113
$16.800.000.0%$16.80$16.80$16.800
$16.80-0.40-2.3%$17.50$17.55$16.751,284,254
$17.20+1.05+6.5%$16.00$17.75$15.453,429,787
$16.15+0.05+0.3%$16.60$17.35$16.103,792,863
$16.10+0.257+1.6%$15.15$16.10$15.151,328,477
$15.840.000.0%$15.84$15.84$15.840
$15.840.000.0%$15.84$15.84$15.840
$15.840.000.0%$15.84$15.84$15.840
$15.84-0.614-3.7%$16.46$16.57$15.84464,337
$16.46-0.112-0.7%$16.57$16.68$16.40178,692
$16.570.000.0%$16.40$16.68$16.4098,369
$16.57+0.223+1.4%$16.46$16.57$16.29245,905
$16.34+0.056+0.3%$16.29$16.40$16.23148,347
$16.29-0.279-1.7%$16.57$16.57$16.29135,188
$16.57+0.167+1.0%$16.40$16.85$16.40163,512
$16.40-0.167-1.0%$16.57$16.74$16.29277,346
$16.57-0.056-0.3%$16.74$16.74$16.46162,457
$16.62-0.279-1.7%$16.90$16.96$16.62137,880
$16.90+0.335+2.0%$16.57$16.90$16.57316,135
$16.570.000.0%$16.51$16.62$16.40138,314
$16.57+0.167+1.0%$16.46$16.68$16.29121,822
$16.400.000.0%$16.34$16.46$16.2965,073
$16.40-0.502-3.0%$16.85$16.85$16.18341,464
$16.90+0.39+2.4%$16.46$16.90$16.34314,904
$16.51+0.781+5.0%$16.18$17.18$16.18989,950
$15.73-0.056-0.4%$15.84$15.84$15.62187,072
$15.79-0.167-1.0%$15.95$15.95$15.7972,061
$15.95-0.167-1.0%$16.01$16.23$15.84205,008
$16.12+0.167+1.0%$15.95$16.12$15.84206,725
$15.95-0.112-0.7%$16.12$16.12$15.90124,456
$16.07-0.112-0.7%$16.18$16.18$15.79249,873
$16.18-0.056-0.3%$16.23$16.34$16.12102,977
$16.23+0.112+0.7%$16.07$16.29$16.07108,221
$16.12-0.056-0.3%$16.18$16.23$16.0784,668
$16.18-0.056-0.3%$16.18$16.23$16.01151,374
$16.23+0.056+0.3%$16.18$16.29$16.07116,350
$16.18+0.056+0.3%$16.12$16.18$16.0170,257
$16.12-0.335-2.0%$16.51$16.51$16.07246,372
$16.46-0.112-0.7%$16.46$16.51$16.34146,349
$16.57+0.223+1.4%$16.29$16.57$16.29120,139

Splits

4 splits since 2014 · TWSE:4155 · every price before a split is adjusted for it

DayRatioWhat
1-for-1.1157Consolidation
54-for-49Split
101-for-84Split
13-for-10Split
Ticker
TWSE:4155
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
TWSE
Currency
TWD

What changed lately

Latest news

All OK Biotech Co., Ltd. news

OK Biotech Co., Ltd. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
3 in the last 12 months · 3 in all · newest Jun 9, 2026 · oldest 2026
Decks
1 deck · latest Sep 17, 2020

Valuation

P/E 7.5× against a median of 12.1×: 3rd lowest of 8 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$2.48B TWD
P/E
7.5×
EV/sales
1.6×
EV/EBITDA
7.9×
Price/book
0.7×
Gross margin
31.1%
Operating margin
14.3%
Net margin
15.8%
Debt to equity
0.4×
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
OK Biotech Co., Ltd. · TWSE:4155US$55.10MUS$75.16M7.5×1.6×7.9×0.7×15.8%0.4×n/a
Vincent Medical Holdings Limited · HKEX:1612US$57.26MUS$62.46M4.3×0.5×2.9×0.6×11.2%0.3×n/a
REMED Co., Ltd. · KRX:302550US$57.14MUS$51.29M37.5×2.5×20.4×2.0×7.6%0.1×n/a
Enzymatica AB · OMXSTO:ENZYUS$55.08MUS$55.77Mn/a11.1×n/a6.0×−80.5%0.1×n/a
LENSAR, Inc. · NASDAQ:LNSRUS$54.83MUS$44.40M1.6×0.7×18.0×5.0×56.1%0.2×0.76
P&S Robotics Co., Ltd. · KRX:460940US$54.38MUS$33.62M26.6×5.9×36.6×1.7×36.0%0.0×n/a
Creo Medical Group PLC · LSE:CREOUS$54.06MUS$49.48M7.8×6.3×n/a0.9×88.3%0.1×n/a
Crystalvue Medical Co Ltd · TPEX:6527US$53.82MUS$52.19M12.1×1.8×8.7×1.7×15.5%0.0×n/a
3D Global Biotech Inc. · TPEX:6808US$53.26MUS$38.17M26.4×6.1×17.5×2.4×32.2%0.0×n/a
Outset Medical, Inc. · NASDAQ:OMUS$53.03MUS$14.77Mn/a0.1×n/a0.6×−58.3%1.2×1.74
NeurAxis, Inc. · AMEX:NRXSUS$52.99MUS$48.80Mn/a7.5×n/a14.6×−185.2%0.1×1.77
Median of the othersUS$54.22MUS$49.14M12.1×4.2×17.8×1.9×13.3%0.1×1.74

Events

QuarterResultsShare move
Q1 2023May 11, 2023 · After close+1.2%
Q4 2022Mar 9, 2023 · Before open−0.6%
Q3 2022Nov 9, 2022 · Before open+1.2%
Q2 2022Aug 10, 2022 · Before open−1.5%
Q1 2022May 11, 2022 · Before open−0.9%
Q4 2021Mar 9, 2022 · After close+1.1%
Q3 2021Nov 11, 2021 · Before open0.0%
Quarter to Jun 30, 2021Aug 15, 2021 · After close−1.1%
Quarter to Mar 31, 2021May 12, 2021 · Before open−2.6%
Quarter to Dec 31, 2020Mar 31, 2021 · Before open−0.6%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2020)Investor deck13 slidesSep 17, 2020

Open Decks

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.56B1.67B1.19B1.48B1.26B1.48B1.24B1.12B1.23B1.04B
Cost of revenue1.13B1.39B995.1M1.14B1.08B1.16B945.1M818.2M945.0M829.9M
Gross profit429.3M275.7M196.9M345.0M186.8M326.0M296.1M302.1M288.1M210.6M
Research and development59.0M57.9M46.7M48.7M28.7M45.5M32.6M40.8M32.6M20.2M
Selling, general and administrative159.6M98.9M73.9M68.5M62.7M72.1M76.1M70.3M68.2M58.0M
Operating income107.9M57.2M-12.1M211.6M49.3M170.1M147.5M141.7M130.6M108.0M
Depreciation and amortization93.6M72.4M75.5M67.9M55.9M50.1M41.6M30.3M23.4M25.5M
EBITDA201.5M129.6M63.5M279.5M105.2M220.2M189.0M172.0M154.0M133.5M
Interest expense10.9M6.23M9.00M11.4M8.08M8.12M6.12M5.30M4.02M3.58M
Income before tax103.9M127.1M8.03M175.6M46.1M151.7M143.4M201.6M163.2M132.6M
Income tax6.74M20.8M9.62M38.9M14.7M30.4M30.7M41.1M36.4M47.4M
Net income82.4M94.0M2.95M143.5M31.4M129.7M125.8M161.4M126.8M85.2M
Earnings per share, basic0.490.640.021.080.261.281.412.041.821.25

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents314.5M277.5M323.0M596.4M599.9M566.7M332.3M184.4M455.7M164.3M
Short-term investments12.6M13.0M42.3M40.2M44.8M
Receivables409.8M571.5M488.6M409.5M404.9M306.1M290.5M259.6M209.0M222.2M
Inventory456.0M530.5M394.0M422.9M375.6M349.1M365.4M272.5M182.8M162.0M
Current assets1.25B1.47B1.32B1.53B1.49B1.28B1.04B802.8M887.0M571.2M
Property, plant and equipment874.7M659.4M606.0M553.2M517.3M515.8M446.7M
Goodwill353.5M353.5M23.6M23.6M29.6M29.6M29.6M28.8M
Total assets3.85B3.70B3.07B3.06B2.81B2.54B2.22B1.85B1.88B1.50B
Accounts payable116.4M195.4M199.1M244.6M238.5M205.7M217.1M197.3M146.6M182.9M
Current liabilities547.6M744.8M578.1M828.2M700.6M653.4M603.2M325.1M482.7M318.6M
Long-term debt606.5M322.0M91.9M383.0M401.8M123.9M280.6M255.7M195.4M232.0M
Total debt1.03B779.4M333.0M780.6M735.7M305.3M534.1M258.8M386.0M291.0M
Total liabilities1.27B1.13B672.3M1.21B1.11B795.9M918.4M582.7M678.1M550.6M
Shareholders' equity2.51B2.49B2.40B1.84B1.70B1.73B1.29B1.25B1.21B944.8M
Shares outstanding167.5M146.4M128.4M132.4M120.4M101.3M89.3M79.0M69.7M68.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations319.6M65.9M2.93M240.5M21.9M147.7M45.2M128.8M102.8M260.7M
Capital spending-409.1M-374.7M-437.1M-294.2M-86.5M-79.8M-78.0M-28.4M-88.0M-57.0M
Free cash flow-89.6M-308.8M-434.1M-53.7M-64.6M67.9M-32.8M100.4M14.7M203.7M
Cash from investing-398.5M-444.9M-358.4M-294.2M-174.5M-127.0M-85.5M-62.2M-96.6M-67.6M
Cash from financing113.0M338.0M82.1M50.3M185.7M215.8M185.1M-337.9M285.2M-104.1M
Dividends paid-43.8M-44.1M-144.6M-94.9M-131.8M-112.1M-166.4M-111.3M-100.4M-100.2M
Share buybacks-33.3M02.55B-5.73M-39.6M00
Change in cash37.0M-45.6M-273.4M-3.44M33.1M234.4M147.9M-271.3M291.4M88.6M

Open Financials

Cap table

Built by 6ix from OK Biotech Co., Ltd.’s releases

Common shares
117,162,283
Fully diluted
117,162,283

Fully diluted

LineShares
Common shares117,162,283

Share count over time

CountShares
Nov 22, 2026117,162,283

Open Cap table

Shareholders

Register

HolderSharesOf the companyAs of
禾群投資股份有限公司6.14M4.9%Oct 31, 2026
廷發投資有限公司5.73M4.6%Oct 31, 2026
尚順投資股份有限公司1.89M1.5%Oct 31, 2026
貝喜股份有限公司1.75M1.4%Oct 31, 2026
藍世萬965K0.77%Oct 31, 2026
劉祐慈767K0.61%Oct 31, 2026
賴家德242K0.19%Oct 31, 2026
王振綱130K0.10%Oct 31, 2026
謝文彬117K0.09%Oct 31, 2026
何麗芬48,0990.04%Oct 31, 2026
All 18 holders
HolderSharesOf the companyAs of
李安原25,8540.02%Oct 31, 2026
侯奇政17,5830.01%Oct 31, 2026
柯怡振1,597<0.01%Oct 31, 2026
呂淨君00.00%Oct 31, 2026
許晉源00.00%Oct 31, 2026
陳谷泉00.00%Oct 31, 2026
陳清標00.00%Oct 31, 2026
林詩怡00.00%Oct 31, 2026

Funds

HolderSharesValueAs of
Emerging Markets Core Equity 2 Portfolio102KUS$45,207Jul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF92,214US$41,087Jul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF77,572US$34,563Jul 31, 2026
Emerging Markets Social Core Equity Portfolio24,000US$10,666Jul 31, 2026
Emerging Markets ex China Core Equity Portfolio23,000US$10,222Jul 31, 2026
The Emerging Markets Small Cap Series22,000US$9,778Jul 31, 2026
World ex U.S. Core Equity Portfolio21,000US$9,333Jul 31, 2026
Emerging Markets Targeted Value Portfolio11,000US$4,889Jul 31, 2026
Avantis Emerging Markets Small Cap Equity ETF1,000US$472May 31, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about OK Biotech Co., Ltd.